UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path forward for the development and discovery of new drugs.

Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug ...

PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced ...

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek ...

Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease ...

Identifying a key protein’s role could improve the common mental health medications and point to new treatments for inflammation-related diseases, VCU medicinal chemist Youzhong Guo says.

The Institute of Cancer Research, London, which helped develop the drug, welcomed the move. A twice-a-day pill for the most ...

Results from a clinical trial showed that capivasertib plus the hormone therapy fulvestrant increased the time before the ...

However, it's possible that other drugmakers could be more interested in teaming up with Recursion with the FDA promoting the ...

Recursion Pharmaceuticals, a trailblazing TechBio company, has made a significant stride in the realm of oncology by dosing the first patient in its Phase 1 clinical trial for a potential B-cell ...